Trilogy Capital Inc.: KR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Trilogy Capital Inc. on KR, newest first. How the timeline and the estimate are built.
Trilogy Capital Inc. held 4,738 KR shares at 2026-06-30 per its 13F-HR filed 2026-07-06.
the latest 13F is the newest step
- period ended2026-06-3013F 4,738 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $263,083.
13F-HR 0001722512-26-000004 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 4,738 sharesChange vs previous 13F -203 shares
0.02% of the 13F portfolio, value $342,819.
13F-HR 0001722512-26-000003 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 4,941 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $308,694.
13F-HR 0001722512-26-000001 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,941 sharesChange vs previous 13F +3 shares
0.02% of the 13F portfolio, value $333,051.
13F-HR 0001722512-25-000007 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,938 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $354,180.
13F-HR 0001722512-25-000006 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,938 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $334,232.
13F-HR 0001722512-25-000004 filed by Trilogy Capital Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).